Company: SMNR
Filing Date: 2025-04-21
Form Type: S-4/A
Source: 0001193125-25-087342
Chunk: 574

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-04-21
Form: S-4/A
Chunk 574
---
 nominating and corporate governance committee. Audit Committee Huifeng Chang, Jim Mao and Kevin D. Vassily serve as members of the Denali Audit Committee. Denali’s board of directors has determined that each of Huifeng Chang, Jim Mao and Kevin D. Vassily are independent under the applicable SEC rules. Kevin Vassily serves as the Chair of the Denali Audit Committee. Under the applicable SEC rules, Denali is required to have at least three members of the audit committee, all of whom must be independent within one year of the listing of the Denali Class A Ordinary Shares. Each member of the Denali Audit Committee is financially literate and Denali’s board of directors has determined that Kevin Vassily qualifies as an “audit committee financial expert” as defined in applicable SEC rules. The Denali Audit Committee is responsible for:

| • |     | meeting with Denali’s independent registered public accounting firm regarding, among other issues, audits, and adequacy of Denali’s accounting and control systems; |

| • |     | monitoring the independence of the independent registered public accounting firm; |

| • |     | verifying the rotation of the lead (or coordinating) audit partner having primary responsibility for the audit and the audit partner responsible for reviewing the audit as required by law; |

| • |     | inquiring and discussing with management Denali’s compliance with applicable laws and regulations; |

| • |     | pre-approving all audit services and permitted non-audit services to be performed by Denali’s independent registered public accounting firm, including the fees and terms of the services to be performed; |

| • |     | appointing or replacing the independent registered public accounting firm; |

| • |     | determining the compensation and oversight of the work of the independent registered public accounting firm (including resolution of disagreements between management and the independent auditor regarding financial reporting) for the purpose of preparing or issuing an audit report or related work; |

| • |     | establishing procedures for the receipt, retention and treatment of complaints received by Denali regarding accounting, internal accounting controls or reports which raise material issues regarding Denali’s financial statements or accounting policies; |

| • |     | monitoring compliance on a quarterly basis with the terms of the IPO and, if any noncompliance is identified, immediately taking all action necessary to rectify such noncompliance or otherwise causing compliance with the terms of the IPO; and |

| • |     | reviewing and approving all payments made to Denali’s existing shareholders, executive